SCANurse, a London-based digital health company, has announced it is one of 10 companies to reach the final stage of the prestigious $10M Qualcomm Tricorder XPRIZE, a 3.5-year global competition sponsored by the Qualcomm Foundation for teams to develop a consumer-focused, mobile device capable of diagnosing and interpreting a set of 15 medical conditions and capturing five vital health metrics.
Triteq were delighted to hear this news and thrilled that our client has been shortlisted to the final 10! Our client, Anil didn’t hesitate to thank those who had provided support. “I would firstly like to thanks all those that helped us get this far in particular, Triteq, Kingston University, Skin Analytics, UCL and Owlstone. “
Launched in January 2012, the competition encourages the development of a device much like the medical Tricorder of Star Trek® fame, moving it from science fiction to science reality. During the Qualifying Round, each team was required to submit an entry that addressed safety, user experience and a health assessment evaluation. The judging panel, comprised of various digital health and medical industry experts, reviewed 21 team submissions from nine countries and selected the 10 most credible entries.
“We are excited to be chosen as one of three European finalists for the Qualcomm Tricorder XPRIZE,” said Anil Vaidya, founder of SCANurse. “The calibre of teams competing in this competition is extremely high so we are thrilled to advance and are grateful to our engineering and design partners who helped contribute to the success of our entry.”